HOME > TOP STORIES
TOP STORIES
-
BUSINESS Gilead’s Japan Revenue Up 15% in 2025 as Trodelvy Gains Traction
March 19, 2026
-
BUSINESS Incyte Looks to More Than Double International Business by 2030: CEO
March 18, 2026
-
REGULATORY Japan Sets Up Radiopharma Discovery Hub in Fukushima, Targets Rare Cancers
March 18, 2026
-
BUSINESS BMS Japan “On Track” to Double Sales by 2032 as Launch Wave Nears
March 17, 2026
-
BUSINESS SSP Appoints Yoko Motoshima as New President
March 16, 2026
-
BUSINESS PMP Returns Slam Drug Makers' Leading Products, Prazaxa Cut 45%: Jiho Poll
March 13, 2026
-
BUSINESS Lilly to Invest Additional 20 Billion Yen in Japan's Seishin Plant
March 13, 2026
-
REGULATORY Chuikyo OKs Listing of J&J’s Rybrofaz, Peak Sales Seen at 43.8 Billion Yen
March 12, 2026
-
REGULATORY Truqap Price Cut Set at 10.7% from June under CEA Scheme
March 12, 2026
-
ACADEMIA CAR-T Reimbursement Insufficient, Kyoto University Hospital Chief Warns
March 11, 2026
-
BUSINESS Minimum Price Hike, Spillover Abolition Win Industry Support in FY2026 Reform: Jiho Poll
March 10, 2026
-
REGULATORY Panel Clears Zolgensma Intrathecal Form to Expand Use in Older SMA Patients
March 10, 2026
-
BUSINESS Drug Pricing Reform Draws Sharp Industry Backlash in Jiho Poll
March 9, 2026
-
REGULATORY Avastin Price to Be Axed by 45% as G1 Rule Hits Originator Biologics
March 6, 2026
-
REGULATORY Forxiga Slapped with 36% Price Cut on PMP Return in FY2026 Revision
March 6, 2026
-
BUSINESS Positive Price Revisions Seen at Several Firms in FY2026 Reform: Poll
March 6, 2026
-
REGULATORY Japan Panel Clears Joenja, Dojolvi, Bayer MRI Contrast Agent
March 6, 2026
-
REGULATORY Japan Drug Prices to Fall 4% in FY2026 Revision: Official Gazette
March 5, 2026
-
BUSINESS Takeda Targets Psoriasis Market with Zasocitinib, Touts Edge in TYK2 Selectivity
March 4, 2026
-
BUSINESS Sumitomo Regains Growth Momentum, Eyes 350 Billion Yen from 2 Key Drugs in FY2028
March 3, 2026
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
